IP Verse

Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same - EP3332773

The patent EP3332773 was granted to Eirgen Pharma on Oct 14, 2020. The application was originally filed on Mar 14, 2014 under application number EP18155036A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3332773

EIRGEN PHARMA
Application Number
EP18155036A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Jul 24, 2020
Publication Date
Oct 14, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DSM NUTRITIONAL PRODUCTSMay 26, 2021KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (36) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20080998308
DESCRIPTIONWO2007US61521
DESCRIPTIONWO2008US61579
DESCRIPTIONUS6645527
OPPOSITIONEP0116755
OPPOSITIONEP0157695
OPPOSITIONEP0413828
OPPOSITIONEP0548448
OPPOSITIONEP0631781
OPPOSITIONEP2478909
OPPOSITIONJP2893140B
OPPOSITIONKR100844256B
OPPOSITIONWO0006126
OPPOSITIONWO03007916
OPPOSITIONWO03059358
OPPOSITIONWO03086321
OPPOSITIONWO2004098507
OPPOSITIONWO2005087194
OPPOSITIONWO2006018119
OPPOSITIONWO2006072940
OPPOSITIONWO2006094782
OPPOSITIONWO2007092755
OPPOSITIONWO2008074144
OPPOSITIONWO2008134512
OPPOSITIONWO2009101131
OPPOSITIONWO2009101132
OPPOSITIONWO2009101135
OPPOSITIONWO2010008976
OPPOSITIONWO2011048144
OPPOSITIONWO2012163836
OPPOSITIONWO9116899
OPPOSITIONWO9209271
OPPOSITIONWO9901111
SEARCHWO2008134512
SEARCHWO2012145491
SEARCHWO9600074

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- United States Pharmacopeia, USP 29-NF 24, Dissolution <711> physical tests and determinations, United States Pharmacopeial Convention, Inc., (20060000), pages 2673 - 2682
OPPOSITION- Anonymous , "Hydroxypropyl Cellulose", Anonymous , Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 317 - 329, ISBN 978-0-85369-792-3, XP093096100
OPPOSITION- M. L. VUEBA et al., "Role of Cellulose Ether Polymers on Ibuprofen Release from Matrix Tablets", Drug Development and Industrial Pharmacy, (20050800), vol. 31, no. 7, pages 653 - 665, XP055821069
OPPOSITION- J.E. HOGAN, "Hydroxypropylmethylcellulose sustained release technology", Drug Development and Industrial Pharmacy, (19890000), vol. 15, no. 6-7, pages 975 - 999, XP009119167
OPPOSITION- A. NOKHODCHI et al., "The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems", Biolmpacts, (20120101), vol. 2, no. 4, pages 175 - 187, XP055216956
SEARCH- RAPURI P B ET AL, "Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter", CALCIFIED TISSUE INTERNATIONAL, NEW YORK, NY, US, (20040201), vol. 74, no. 2, doi:10.1007/S00223-003-0083-8, ISSN 0171-967X, pages 150 - 156, XP002454820 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents